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Nitrolinoleate Inhibits Superoxide Generation,
Degranulation, and Integrin Expression by
Human Neutrophils
Novel Antiinflammatory Properties of Nitric Oxide–Derived Reactive
Species in Vascular Cells
Barbara Coles, Allison Bloodsworth, Stephen R. Clark, Malcolm J. Lewis, Andrew R. Cross,
Bruce A. Freeman, Valerie B. O’Donnell
Abstract—Nitration of unsaturated fatty acids such as linoleate by NO-derived reactive species forms novel derivatives
(including nitrolinoleate [LNO2]) that can stimulate smooth muscle relaxation and block platelet activation by either
NO/cGMP or cAMP-dependent mechanisms. Here, LNO2 was observed to inhibit human neutrophil function. LNO2, but
not linoleic acid or the nitrated amino acid 3-nitrotyrosine, dose-dependently (0.2 to 1 mol/L) inhibited superoxide
(O2·) generation, Ca2 influx, elastase release, and CD11b expression in response to either phorbol 12-myristate
13-acetate or N-formyl-Met-Leu-Phe. LNO2 did not elevate cGMP, and inhibition of guanylate cyclase by 1H-
[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one did not restore neutrophil responses, ruling out a role for NO. In contrast,
LNO2 caused elevations in intracellular cAMP in the presence and absence of phosphodiesterase inhibition, suggesting
activation of adenylate cyclase. Compared with phorbol 12-myristate 13-acetate–activated neutrophils, N-formyl-Met-
Leu-Phe–activated neutrophils were more susceptible to the inhibitory effects of LNO2, indicating that LNO2 may inhibit
signaling both upstream and downstream of protein kinase C. These data suggest novel signaling actions for LNO2 in
mediating its potent inhibitory actions. Thus, nitration of lipids by NO-derived reactive species yields products with
antiinflammatory properties, revealing a novel mechanism by which NO-derived nitrated biomolecules can influence the
progression of vascular disease. (Circ Res. 2002;91:375-381.)
Key Words: nitric oxide  nitrolinoleate  neutrophils  atherosclerosis  peroxynitrite
Nitric oxide is a free radical signaling mediator generatedby the healthy endothelium to maintain vascular ho-
meostasis through the regulation of blood pressure and
leukocyte-platelet activation. When generated at elevated
levels during inflammation by inducible NO synthase in a
variety of cell types, NO is readily transformed into potent
nitrating and nitrosating species, including peroxynitrite
(ONOO), nitrogen dioxide (NO2), and nitrous acid (HONO).
These species can react with unsaturated lipids, forming both
oxidized and nitrated products, including nitro, nitrito, and
nitroepoxy derivatives.1–4 Several recent studies have dem-
onstrated in vivo generation of nitrated lipids. For example,
bovine cardiac muscle and human plasma contain species
with chromatographic and mass spectral properties identical
to those of nitrated arachidonate and linoleate, whereas
plasma from rats exposed to liver ischemia/reperfusion con-
tains nitrolinoleate5,6 (D.G. Lim, B.A. Freeman, unpublished
data, 2002). Treatment of LDL with nitrating/nitrosating and
oxidizing species that are generated during myeloperoxidase
oxidation of nitrite (NO2) causes its modification to a form
recognized by the macrophage scavenger receptor CD36.7,8
Also, macrophage uptake of LDL treated with nitrating/
nitrosating species stimulates cholesteryl ester synthesis,
intracellular cholesterol and cholesteryl ester accumulation,
and foam cell formation.9,10 Finally, synthetic nitrated lipids
derived from either arachidonate or linoleate inhibit multiple
indices of platelet activation and cause smooth muscle relax-
ation5,11 (D.G. Lim, B.A. Freeman, unpublished data, 2002).
These observations raise the possibility that nitrated lipids
could modulate atherogenesis and/or inflammation in vivo.
Activation of phagocytic leukocytes, including neutrophils,
is a central feature of inflammatory disease.12–16 For example,
neutrophil rolling and adhesion to the endothelium are en-
hanced in apoE and double apoE/LDL receptor–knockout
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mice, whereas neutrophils from septic patients show alter-
ations in integrin expression and O2· generation.13–16 Also,
mice deficient in adhesion molecules or chemokines and their
receptors show impaired immune responses and diminished
atherosclerosis.12,17–19 Neutrophil function in vivo can be
regulated through NO- and eicosanoid-dependent mecha-
nisms.20–22 In this regard, nitrated unsaturated lipids formed
by reaction with NO-derived reactive nitrogen species are of
potential interest, inasmuch as they could influence neutro-
phil activation through either reactivity and may lead to the
development of novel therapeutic strategies for inflammation.
A synthetic nitrated lipid, nitrolinoleate (LNO2), which is
structurally similar to that generated by ONOO- or NO2-
induced linoleate nitration, is reported in the present study to
inhibit N-formyl-Met-Leu-Phe (fMLP)- and phorbol 12-my-
ristate 13-acetate (PMA)-mediated activation of human neu-
trophils.1 Superoxide generation, degranulation, and CD11b
expression were inhibited at LNO2 concentrations 1
mol/L and occurred in concert with attenuated elevations in
intracellular Ca2 and increased intracellular cAMP. Com-
pared with PMA-activated neutrophils, fMLP-activated neu-
trophils were more susceptible to LNO2 inhibition, indicating
that LNO2 may inhibit signaling upstream and downstream of
protein kinase C. In aggregate, these data reveal that nitrated
lipids potently inhibit leukocyte activation and demonstrate
novel mechanisms by which NO-derived nitrated biomol-
ecules may attenuate tissue inflammatory responses.
Materials and Methods
Materials
Lymphoprep was obtained from Nycomed Pharma. Unless otherwise
stated, all other reagents were obtained from Sigma-Aldrich Ltd.
Synthesis and Purification of LNO2
The synthesis and purification of LNO2 have recently been described
elsewhere and have been adapted from previous strategies for the
synthesis of conjugated nitroalkenes via nitroselenylation of alk-
enes.11,23,24 Briefly, linoleic acid (LA), HgCl2, PheSeBr, and AgNO2
(1.0:1.3:1.0:1.0 [mol/mol]) were combined in THF-acetonitrile (1:1
[vol/vol]), with a final concentration of 0.15 mol/L LA. The mixture
was degassed and stirred at 25°C in the dark for 1.5 hours, the
supernatant was recovered, and solvent was removed in vacuo. Lipid
was solvated again in THF, and a 10-fold molar excess of H2O2 was
added to the lipid mixture after cooling to 0°C. After 20 minutes, the
solution was warmed to 25°C until gas evolution was noted. The
solution was cooled to 10°C, followed by stirring at 25°C for 30
minutes. Lipids were extracted and then chromatographed on a silica
gel column (250 to 400 mesh) using a hexane-CHCl3 step gradient
(5% increments from 0% to 30% CHCl3), with LNO2 predominantly
eluting in the 20% to 30% CHCl3 fraction, as determined by
negative-ion-mode mass spectroscopic monitoring of fractions. Fur-
ther purification was accomplished by high pressure liquid chroma-
tography using 0.1% acetic acid in 50% to 90% CH3OH gradient on
a 4.6250-m reverse-phase C18 column. LNO2 yields were quan-
tified by elemental analysis of nitrogen content after pyrolysis by
chemiluminescent nitrogen detection (Antek Instruments), with caf-
feine used as a standard. After purification and quantification, LNO2
was stored in CH3OH under inert gas at 80°C. For all cell
experiments, appropriate controls using methanol were carried out to
exclude solvent effects, and methanol concentrations were always
0.1%.
Neutrophil Isolation
Human neutrophils were isolated from 20 mL citrate anticoagulated
whole blood as described.25 Approval for blood donations from
healthy volunteers was given by the Bro Taf Local Research Ethics
Committee, and all donors gave written consent. Briefly, blood was
mixed 1:1 with 0.8% trisodium citrate (wt/vol) and 2% dextran
(wt/vol) in PBS (containing 137 mmol/L NaCl, 2.68 mmol/L KCl,
8.1 mmol/L Na2HPO4, and 1.47 mmol/L KH2PO4) and allowed to
sediment for 45 minutes at 20°C. After this procedure, the upper
plasma layer was underlaid with ice-cold Lymphoprep (2:1 for
plasma/Lymphoprep) and centrifuged (800g, 20 minutes, 4°C). The
pellet was resuspended in ice-cold PBS and 0.4% trisodium citrate
(wt/vol) and centrifuged (400g, 5 minutes). Contaminating erythro-
cytes were removed using 3 cycles of hypotonic lysis. Finally, cells
were resuspended in a small volume of Krebs buffer (100 mmol/L
NaCl, 50 mmol/L HEPES, 5 mmol/L KCl, 1 mmol/L MgCl2,
1 mmol/L NaH2PO4, 1 mmol/L CaCl2, 2 mmol/L D-glucose, and 5
U/mL heparin, pH 7.4), counted, and kept on ice.
Neutrophil Fractionation
For the preparation of subcellular fractions, neutrophils were purified
as described above with the omission of the dextran sedimentation
step. Neutrophils were treated with 2.5 mmol/L diisopropyl fluoro-
phosphate for 10 minutes at 4°C, disrupted in relaxation buffer
(100 mmol/L KCl, 3 mmol/L NaCl, 3.5 mmol/L MgCl2, 1 mmol/L
ATP, 1.25 mmol/L EGTA, and 10 mmol/L PIPES, pH 7.3) by N2
cavitation, and fractionated on a discontinuous Percoll gradient.26,27
This method produces cytosolic and plasma membrane fractions
whose final concentrations were adjusted to 9107 and 1.25109
cell equivalents per milliliter, respectively. Fractions were stored at
80°C for up to 1 year without loss of activity.
Superoxide Generation
Neutrophil O2· generation was determined using superoxide dis-
mutase–sensitive cytochrome c reduction.28 Cells (106) were added
to 2 mL Krebs buffer containing 50 mol/L ferricytochrome c, with
stirring, at 37°C. Cells were activated using either 1 mol/L fMLP
or 1 g/mL PMA, and absorbance was monitored at 550 nm ( 21.1
cm1 · mmol/L for ferrocytochrome c). To confirm O2· generation,
superoxide dismutase (300 U/mL) was added in control experiments.
Where used, the soluble guanylate cyclase (sGC) inhibitor 1H-
[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one (ODQ, 4 mol/L) was
preincubated with neutrophils 20 minutes before the assay. Super-
oxide generation by isolated neutrophil membranes was measured
after the addition of 160 mol/L NADPH to 0.75 mL relaxation
buffer containing 5.4106 cell equivalents of membrane extract per
milliliter, 1.5107 cell equivalents of cytosol per milliliter, 10
mol/L GTP--S, 100 mol/L SDS, and 50 mol/L cytochrome c.
To facilitate the assembly of NADPH oxidase components, all
constituents (excluding NADPH) were preincubated at 25° for 5
minutes before the addition of NADPH. LNO2 (10 mol/L) was
added in ethanol (final concentration 0.1%) either during NADPH
oxidase assembly or immediately before NADPH addition.
Measurement of Neutrophil [Ca2ic]
Neutrophils prepared as described were incubated at 107/mL with 5
mol/L fura 2-AM (Molecular Probes) in Ca2-free Krebs buffer at
37°C for 20 minutes. Then, cells were centrifuged at 400g for 10
minutes, resuspended in Ca2-free Krebs buffer at 107/mL, kept on
ice, and studied within 90 minutes. Fluorescence of neutrophils
(106/mL) was measured using a Perkin-Elmer LS 50B fluorescence
spectrophotometer at 37°C with stirring. Excitation wavelengths
were 340 and 380 nm, with an emission wavelength of 509 nm.
Corrections were applied for autofluorescence (unloaded neutro-
phils), and calibrations were performed by adding 1 mol/L iono-
mycin, 1 mmol/L CaCl2 (to give maximal fluorescence ratio [Rmax]
and minimum fluorescence [Sb]), followed by 5 mmol/L MnCl2 (to
give minimal fluorescence ratio [Rmin] and maximum fluorescence
[Sf]) to fura 2-AM–loaded neutrophils. [Ca2ic] was calculated using
the following equation: [Ca2ic]Kd · Sf · (RRmin)/Sb · (RmaxR),
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where Kd is the dissociation constant of fura 2 under intracellular
conditions (224 nmol/L); Sf and Sb are the maximum and minimum
values of fluorescence, respectively, at 380 nm; and Rmax and Rmin are
the maximum and minimum values of the ratio (340 nm/380 nm)
under Ca2-saturating and Ca2-free conditions, respectively. Fluo-
rescence of neutrophils was monitored on the addition of 1 mol/L
fMLP alone, 5 mol/L LNO2, or fMLP after a 2-minute preincuba-
tion with LNO2 in the presence of either 1 mmol/L CaCl2 or 100
mol/L EGTA (using Ca2-free Krebs solution).
Determination of CD11b Expression
Expression of CD11b (M integrin, MAC-1) was determined by
flow cytometry.29 Briefly, isolated neutrophils (2106/mL) were
incubated with and without LNO2 (3.6 mol/L) for 2 minutes at
37°C. After this procedure, fMLP (1 mol/L) was added, and
samples were incubated for a further 5 minutes at 37°C. Anti-human
CD11b-FITC (10 L, Serotec) or isotype control was then added,
and samples were incubated for 30 minutes at 4°C. Finally, cells
were washed once with ice-cold PBS and then resuspended in 0.1%
paraformaldehyde-PBS until flow cytometry analysis. Neutrophils
were analyzed on a FACScan flow cytometer (Becton Dickinson)
and identified by forward and side scatter and FITC.
Determination of Neutrophil Degranulation by
Elastase Release
Degranulation of azurophilic granules was determined by elastase
release.30 Briefly, isolated neutrophils were resuspended at
2106/mL Krebs buffer containing 1 g/mL cytochalasin B and 40
mol/L MeO-Suc-Ala-Ala-Pro-Val-MCA at 37°C with stirring.
After 5 minutes, 1 mol/L fMLP was added, and fluorescence was
monitored (excitation wavelength 380 nm, emission wavelength 460
nm). In some experiments, 3 mol/L LNO2 was added 2 minutes
before fMLP.
Determination of cAMP and cGMP
For cAMP, neutrophils (2106/mL) in Krebs buffer were prewarmed
to 37°C for 3 minutes. Then, 3.6 mol/L LNO2 with or without
1 mmol/L 3-isobutyl-1-methylxanthine (IBMX) was added, and
samples were incubated for 1 minute at 37°C. Then, proteins were
precipitated using ice-cold 6% trichloroacetic acid, which was
subsequently removed by washing samples several times with
water-saturated diethyl ether. For cGMP, neutrophils (4106/mL) in
Krebs buffer were incubated for 5 minutes at 37°C with or without
1 mmol/L IBMX, 10 mol/L LNO2, or 10 mol/L 2(N,N-
diethylamino)-diazenolate-2-oxide (DEANONOate). Then, proteins
were precipitated using ice-cold 66% ethanol. Cyclic nucleotides
were determined by radioimmunoassay (Biotrak, Amersham).
Results
LNO2 Inhibits fMLP- or PMA-Induced O2·
Generation by Intact Neutrophils but Not by
Reconstituted NADPH Oxidase
Addition of LNO2 (0.5 to 5 mol/L) to stirred neutrophils in
suspension did not stimulate O2· generation (not shown).
However, LNO2 added to neutrophils 2 minutes before
agonist activation using either 1 mol/L fMLP or 1 g/mL
PMA led to concentration-dependent inhibition of O2· gen-
eration (Figures 1A, 1B, and 1D). In contrast, similar con-
centrations of the parent fatty acid, LA, or the nitrated amino
acid, 3-nitrotyrosine (3-NT), were without effect (Figure 1C).
This indicates that inhibition of neutrophil activation was
specific to LNO2 and was not a feature of all unsaturated
lipids or nitro-containing compounds. Neutrophil membranes
were isolated and assayed for O2· generation in a reconsti-
tuted system after the addition of NADPH. Preincubation of
neutrophil membranes during assembly with 10 mol/L
LNO2 slightly suppressed O2· generation rates, although this
was not significant (Figure 2A). Also, the addition of LNO2 to
the enzyme that had been allowed to preassemble in vitro had
no effect on O2· generation. These data indicate that LNO2
does not inhibit O2· generation through a direct effect on
NADPH oxidase assembly or turnover.
cGMP Synthesis Is Not Involved in Inhibition of
Neutrophil O2· Generation by LNO2
To examine whether NO was involved in the inhibitory
effects of LNO2, the sGC inhibitor ODQ was added. This did
not restore neutrophil O2· generation in response to fMLP
(Figure 2B). Separately, cellular cGMP levels were found to
be unchanged after a 5-minute incubation with LNO2 in
contrast to DEANONOate, which was used as a positive
control (Figure 2C). These data rule out a role for NO
activation of sGC in the inhibitory actions of LNO2.
Effect of LNO2 on CD11b Exposure in Response
to fMLP
Basal neutrophil expression of CD11b, as evidenced by the
difference in fluorescence between cells stained with either
anti-CD11b antibody or isotype control, was not affected by
LNO2 (Figure 3). fMLP activation of neutrophils induced a
Figure 1. LNO2 inhibits neutrophil O2· generation in response to
either PMA or fMLP. O2· generation was measured using cyto-
chrome c reduction as described in Materials and Methods.
Neutrophils (106) in 2 mL Krebs buffer containing 50 mol/L
cytochrome c, with stirring at 37°C, were activated by 1 mol/L
fMLP or 1 g/mL PMA, and absorbance (550 nm) was moni-
tored. LNO2, LA, or 3-NT was added 2 minutes before activa-
tion. A, Time course of O2· generation by fMLP-activated neu-
trophils with/without LNO2 is shown. B, Dose-dependent
inhibition of fMLP-stimulated neutrophil O2· generation by LNO2
is shown. C, LA and 3-NT do not inhibit fMLP-stimulated neu-
trophil O2· generation. D, Dose-dependent inhibition of PMA-
stimulated neutrophil O2· generation by LNO2 is shown. For all
data, values are meanSD (n3). *P0.05 vs no LNO2 after
ANOVA and Bonferroni post hoc test.
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further significant increase in CD11b expression (Figures 3A
and 3C), which was fully inhibited by preincubation of cells
with 3 mol/L LNO2 (Figures 3B and 3C). This indicates that
LNO2 can inhibit neutrophil functions associated with
adhesion.
LNO2 Attenuates fMLP-Induced Degranulation
Pretreatment of neutrophils with 3 mol/L LNO2 blocked
fMLP-induced azurophilic degranulation, as measured by
elastase release, whereas the addition of LNO2 to unstimu-
lated cells had no effect (Figures 4A and 4B). This indicates
that neutrophil functions associated with tissue damage and
bacteriolysis can be attenuated by LNO2.
LNO2 Attenuates Ca2 Mobilization in Response
to fMLP
To examine the mechanisms of LNO2 inhibition of neutrophil
activation, Ca2 mobilization in response to fMLP was
monitored by fura 2-AM fluorescence. On the addition of 1
mol/L fMLP to Ca2-containing samples, a characteristic
increase in [Ca2ic] was observed (Figure 5A). Preincubation
of neutrophils with 3 mol/L LNO2 significantly attenuated
fMLP-induced Ca2 mobilization and accelerated the subse-
quent rate of Ca2 removal, whereas the addition of LNO2 to
unstimulated cells had no effect (Figure 5). In the absence of
external Ca2, LNO2 did not alter the kinetics of Ca2
mobilization (Figure 6), indicating that LNO2 primarily ex-
erted an effect on external Ca2 fluxes in neutrophils.
LNO2 Elevates cAMP in Neutrophils
LNO2 inhibits platelet activation via a cAMP-dependent
pathway.11 To determine whether similar mechanisms are
operative in neutrophils, cAMP was determined after
incubation with LNO2. After a 1-minute incubation with
3.6 mol/L LNO2, a 40% increase in cAMP was observed
(Figure 7). However, in the presence of the phosphodies-
terase inhibitor IBMX, LNO2 caused a 3-fold elevation in
neutrophil cAMP levels. This indicates that LNO2 elevates
cAMP synthesis through the activation of adenylate cy-
clase in neutrophils.
Figure 2. LNO2 does not block O2· generation in isolated neu-
trophil membranes, and inhibition of neutrophil O2· generation
does not involve sGC activation. A, O2 generation was deter-
mined as described in Materials and Methods after the addition
of 160 mol/L NADPH to 0.75 mL relaxation buffer containing
5.4106 cell equivalents (cell eq) of membrane extract per millili-
ter, 1.5107 cell eq of cytosol per milliliter, 10 mol/L GTP--S,
100 mol/L SDS, and 50 mol/L cytochrome c. To allow
assembly of NADPH oxidase components, all constituents
(excluding NADPH) were preincubated at 25°C for 5 minutes
before the addition of NADPH. LNO2 (10 mol/L) was added in
ethanol (final concentration 0.1%) either during NADPH oxidase
assembly (middle bar) or immediately before NADPH (right bar).
B, O2· generation of neutrophils in response to 1 mol/L fMLP
was determined as in Figure 1 after preincubation with/without 3
mol/L LNO2. Where used, 4 mol/L ODQ was preincubated
with neutrophils for 20 minutes before assay. C, cGMP synthe-
sis by neutrophils was determined as described in Materials and
Methods after 5 minutes of incubation with 10 mol/L LNO2 and
10 mol/L DEANONOate (DEANO) with/without 1 mmol/L IBMX.
For all data, values are meanSD (n3), and all experiments
were repeated at least 3 times with neutrophils obtained from
different donors (B). *P0.05 vs control after ANOVA and Bon-
ferroni post hoc test (C). Bars marked with asterisks are not sig-
nificantly different from each other.
Figure 3. LNO2 attenuates fMLP-stimulated neutrophil CD11b expres-
sion. Cells (2106/mL) were incubated with/without 3.6 mol/L LNO2
for 2 minutes and then activated by 1 mol/L fMLP for 5 minutes at
37°C. Anti-human CD11b-FITC or isotype control was then added,
and cells were incubated for 30 minutes at 4°C. Cells were washed
once with PBS and then fixed with 0.1% paraformaldehyde/PBS for
FACScan analysis, as described in Materials and Methods. A, Fluores-
cence shift induced by fMLP in control neutrophils is shown. B, LNO2
inhibits fMLP-induced CD11b expression. C, Percentages of cells in
population designated M1 in panels A and B are shown. For all data,
values are meanSD (n3), and all experiments were repeated at
least 3 times on different donors. *P0.05 vs fMLP after ANOVA and
Bonferroni post hoc test.
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Discussion
Nitrated lipid has recently been found in human plasma,
bovine cardiac tissue, and plasma from a rat model of liver
ischemia/reperfusion, with extensive nitration and oxidation
of biomolecules also occurring in human atheroma5,6,31 (D.G.
Lim, B.A. Freeman, unpublished data, 2002). Nitrated lipids,
including LNO2, possess vascular protective properties
through the inhibition of platelet activation and promotion of
smooth muscle relaxation5,11 (D.G. Lim, B.A. Freeman,
unpublished data, 2002). In the present study, the influence of
LNO2 on human neutrophil functional responses was exam-
ined to characterize their bioactivity toward proinflammatory
leukocytes, which are central to the pathogenesis of athero-
sclerosis. LNO2 (0.1 to 1 mol/L) inhibited neutrophil acti-
vation in response to PMA or fMLP, as indicated by the
inhibition of O2· generation, Ca2 mobilization, azurophilic
degranulation, and CD11b expression. This reveals that lipid
nitration results in the formation of an antiinflammatory and
vascular-protective product that potently attenuates multiple
leukocyte functions.
Neutrophil cytotoxicity requires efficient degranulation to
release proteases and other degradative enzymes. In the
present study, LNO2 effectively blocked fMLP-induced
azurophilic degranulation, indicating that events associated
with bacterial killing and cell damage are attenuated by
nitrated lipids (Figure 4). The cell surface glycoprotein,
CD11b (M integrin, MAC-1), is expressed as a heterodimer
with CD18 (C receptor type 3) on the surface of leukocytes in
response to activating agonists such as fMLP and is involved
in adhesion to endothelial cells and in transendothelial mi-
gration to inflammatory sites.32,33 Recruitment of leukocytes
to the arterial wall is an important event in atherogenesis and
plaque rupture.12,17–19,32,33 This is mediated via leukocyte
integrin receptors, including CD11b, and is modulated by a
variety of both endothelium- and leukocyte-derived lipid
oxidation products and free radicals, including O2·, NO,
prostaglandins, and isoprostanes.34–42 Inhibition of fMLP-
induced CD11b expression by LNO2 indicates that nitrated
lipids also modulate leukocyte responses associated with the
development of vascular disease (Figure 3).
Stimulation of neutrophils by fMLP or PMA causes trans-
location of at least 3 different cytosolic proteins (p67-phox,
p47-phox, and p21-rac1) to the membrane, where they
interact with 2 membrane-bound proteins (gp91-phox and
p22-phox) to form the active O2·–generating NADPH oxi-
dase complex. To determine whether LNO2 exerted its
inhibitory actions directly on NADPH oxidase or prevented
complex assembly, neutrophil membranes were isolated and
assayed for O2· generation in a reconstitution system after
the addition of NADPH. The lack of inhibition by LNO2 in
this assay indicates that LNO2 exerts its inhibitory effects
upstream of NADPH oxidase (Figure 2A).
Figure 5. LNO2 attenuates fMLP-stimulated Ca2 mobilization in
neutrophils in the presence of extracellular Ca2. Neutrophils
labeled with fura 2-AM as described in Materials and Methods
were stimulated with 1 mol/L fMLP, as indicated by arrows, in
the presence of 1 mmol/L Ca2, and fluorescence was moni-
tored at 37°C with stirring. A, Ca2 mobilization of neutrophils
with/without 2-minute preincubation with 3 mol/L LNO2. B,
Control experiments showing no effect of 3 mol/L LNO2 on
control neutrophils. C, Maximum Ca2 elevations recorded on
addition of 1 mol/L fMLP to control or 3 mol/L LNO2–treated
neutrophils. [Ca2ic] indicates intracellular Ca2 concentration.
For all data, values are meanSD (n3), and all experiments
were repeated at least 3 times with neutrophils obtained from
different donors. *P0.01 vs fMLP alone after independent t
test.
Figure 4. LNO2 inhibits fMLP-stimulated neutrophil degranula-
tion. Elastase release was measured by hydrolysis of MeO-Suc-
Ala-Ala-Pro-Val-MCA as described in Materials and Methods. A,
Cells (2106) were incubated with 1 g/mL cytochalasin B and
40 mol/L MeO-Suc-Ala-Ala-Pro-Val-MCA at 37°C, with stirring,
for 5 minutes before activation using 1 mol/L fMLP, as indi-
cated by arrow. In some experiments, 3 mol/L LNO2 was
added 2 minutes before fMLP. B, Rates of fluorescence change
after fMLP activation of neutrophils with/without 3 mol/L LNO2
were determined. For all data, values are meanSD (n3), and
all experiments were repeated at least 3 times with neutrophils
obtained from different donors. *P0.05 vs fMLP after ANOVA
and Bonferroni post hoc test.
Coles et al Nitrolinoleate Inhibits Neutrophil Activation 379
 at Cardiff University on February 19, 2014http://circres.ahajournals.org/Downloaded from 
There are at least 2 potential mechanisms by which nitrated
lipids may exert cell signaling. The inhibition of platelet
activation by LNO2 requires cAMP synthesis, whereas stim-
ulation of smooth muscle relaxation by LNO2 or nitrated
arachidonate involves cellular metabolism of the nitro func-
tional group to NO5,11 (D.G. Lim, B.A. Freeman, unpublished
data, 2002). An elevation in either cGMP or cAMP can
inhibit neutrophil function and is consistent with the observed
effects of LNO2 on agonist-induced Ca2 elevations.34–39
However, cGMP was ruled out because (1) elevations in
response to LNO2 did not occur and (2) inhibition of sGC did
not restore neutrophil activation (Figure 2). In contrast, LNO2
increased intracellular cAMP, in the presence and absence of
IBMX, suggesting an involvement of this metabolite (Figure
7). Previous studies have shown that cAMP inhibits fMLP-
but not PMA-stimulated neutrophil O2· generation. This
indicates that cAMP acts upstream of protein kinase C.40
Therefore, inhibition of PMA-stimulated O2· generation by
LNO2 suggests an additional cAMP-independent mechanism
of action. In support, fMLP-activated neutrophils were con-
siderably more susceptible to the inhibitory effects of LNO2
than when they were stimulated with PMA (Figures 1B and
1D).
This preparation of LNO2 is a mixture of 4 positional
isomers identified using nuclear magnetic resonance and IR
spectroscopy (D.G. Lim, B.A. Freeman, unpublished data,
2002), and this preparation was used because it can be
synthesized with a relatively high yield and purity. Levels of
nitrated lipid in vivo are too low to allow purification of
amounts sufficient for biological studies. Similarly, nitration
of linoleate through oxidant pathways (eg, ONOO and NO2)
in vivo will also form a mixture of LNO2 isomers. Metabo-
lism to release NO by smooth muscle cells is unlikely to be
isomer specific; however, activation of adenylate cyclase
through receptor-dependent pathways may be more effective
with 1 specific isomer.
Data from the present study and others indicate that lipid
nitration results in the formation of compounds that can
signal through either NO- or cAMP-dependent pathways,
with the biological mechanism of action being highly cell
type dependent5,11 (D.G. Lim, B.A. Freeman, unpublished
data, 2002). For example, LNO2 mediates smooth muscle
relaxation through exclusively cGMP-dependent mecha-
nisms, whereas in platelets and neutrophils, there is no role
for NO, with its biological effects being at least partly cAMP
dependent11 (D.G. Lim, B.A. Freeman, unpublished data,
2002, and data in the present study). The reasons for this may
involve (1) different cellular rates of metabolism of LNO2 to
NO and/or (2) differences in the expression of eicosanoid
receptors that activate adenylate cyclase.
In summary, the present study shows that LNO2 potently
blocks multiple neutrophil proinflammatory responses, in-
cluding degranulation, O2· generation, and integrin expres-
sion. This indicates that nitrated lipids will attenuate leuko-
cyte migration and subsequent activation in atherosclerotic
lesions, demonstrating a further vascular protective property
of these compounds in addition to antiplatelet and vasorelax-
ing effects5,11 (D.G. Lim, B.A. Freeman, unpublished data,
2002). These data reveal novel mechanisms by which nitrated
biomolecules modulate cell activation and show how the
presence of the nitro functional group can alter the bioactivity
of lipids through the formation of vascular protective and
antiinflammatory products.
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